Cargando…

ODP650 Impaired Cognition in Patients with Mild Autonomous Cortisol Secretion

BACKGROUND: Limited data describe cognitive deficits in patients with Cushing syndrome (CS). The impact of mild autonomous cortisol secretion (MACS) on cognition is unknown. OBJECTIVE: To determine the impact of MACS on cognitive function. METHODS: Single-center cross-sectional study of adults with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nathani, Rohit, Thangamuthu, Karthik, Singh, Sumitabh, Zhang, Catherine, Suresh, Malavika, Ebbehøj, Andreas, Bancos, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627634/ http://dx.doi.org/10.1210/jendso/bvac150.164

Ejemplares similares

PSAT101 Impaired Muscle Function and Health-Related Quality of Life in Patients with Mild Autonomous Cortisol Secretion
por: Zhang, Catherine D, et al.
Publicado: (2022)

Impaired Muscle Strength and Performance in Patients With Mild Autonomous Cortisol Secretion
por: Zhang, Catherine D, et al.
Publicado: (2021)

THU606 Cognitive Impairment In Patients With Mild Autonomous Cortisol Secretion: A Cross-sectional Study
por: Saini, Jasmine, et al.
Publicado: (2023)

THU603 Bone Fragility In Mild Autonomous Cortisol Secretion: A Cross-Sectional Cohort Study
por: Zhang, Catherine D, et al.
Publicado: (2023)

FRI184 Impact Of Adrenalectomy On Cognition In Patients With Mild Autonomous Cortisol Secretion
por: Saini, Jasmine, et al.
Publicado: (2023)

THU605 Impact Of Abnormal Circadian Cortisol Secretion On Bone Metabolism In Patients With Mild Autonomous Cortisol Secretion
por: Saini, Jasmine, et al.
Publicado: (2023)

SAT-LB37 Frailty in Patients With Mild Autonomous Cortisol Secretion Is Higher Than Patients With Nonfunctioning Adrenal Tumors
por: singh, sumitabh, et al.
Publicado: (2020)

SAT-366 The Impact of Mild Autonomous Cortisol Secretion on Bone Metabolism
por: Athimulam, Shobana, et al.
Publicado: (2019)

RF09 | PSUN05 Increased Frailty in Patients With Functioning Adrenal Adenomas
por: Dogra, Prerna, et al.
Publicado: (2022)

LBSAT59 Overnight Metyrapone Test And Urine Steroid Profiling In Patients Treated With Chronic Opioid Therapy: Prevalence Of Adrenal Insufficiency
por: Saini, Jasmine, et al.
Publicado: (2022)

PSAT024 A Case of Mild Autonomous Cortisol Secretion Managed with Active Surveillance
por: Thakkar, Aditi, et al.
Publicado: (2022)

SAT-368 Natural History Of Adrenal Incidentalomas With And Without Mild Autonomous Cortisol Excess; A Systematic Review And Meta-analysis
por: Elhassan, Yasir, et al.
Publicado: (2019)

FRI185 Post-adrenalectomy Improvement Of Kidney Function In Patients With Mild Autonomous Cortisol Secretion And Nonfunctioning Adrenal Adenoma
por: Rahimi, Leili, et al.
Publicado: (2023)

MON-219 Prevalence and Incidence of Fractures in Patients with Adrenal Adenomas: A Population-Based Study of 1003 Patients
por: Li, Dingfeng, et al.
Publicado: (2020)

SAT-176 Epidemiology of Adrenal Tumors: A Population Based Study of 1287 Patients
por: Ebbehoj, Andreas, et al.
Publicado: (2020)

MON-222 Cardiovascular Risk Factors, Morbidity, and Overall Mortality in Patients with Adrenal Adenomas: A Population-Based Study of 1,003 Patients
por: Zhang, Catherine D, et al.
Publicado: (2020)

SAT341 Even Mild Cortisol Excess Is Unsafe: Use of Mifepristone In Mild Autonomous Cortisol Secretion
por: Cruz, Alegyari Figueroa, et al.
Publicado: (2023)

SUN-LB062 The Impact of Autonomous Cortisol Secretion on Body Composition
por: Delivanis, Danae
Publicado: (2019)

Atypical Adrenocortical Incidentaloma Causing Autonomous Cortisol Secretion and Cardiovascular Complications
por: Gaballa, Salem, et al.
Publicado: (2021)

SAT339 Osteopenia In The Setting of Mild Autonomous Cortisol Secretion
por: Mao, Jimmy J, et al.
Publicado: (2023)

Risk of Mental and Sleep Disorders After the Diagnosis of Adrenal Adenomas: A Population-Based Cohort Study
por: Singh, Sumitabh, et al.
Publicado: (2021)

OR25-05 Increased Overall Mortality and Cardiovascular Morbidity in Patients with Adrenal Incidentalomas and Autonomous Cortisol Secretion: Results of the ENS@T NAPACA-Outcome Study
por: Deutschbein, Timo, et al.
Publicado: (2020)

OR29-2 Mild Autonomous Cortisol Excess (MACE) in Adrenal Incidentalomas - Metabolic Risk Profile and Urinary Steroid Metabolome Analysis in 1208 Prospectively Recruited Patients
por: Prete, Alessandro, et al.
Publicado: (2019)

ODP061 When cortisol and catecholamines combine in a severe endocrine condition
por: Webster, John, et al.
Publicado: (2022)

OR12-4 Metabolic Profiling in Adrenal Tumors Demonstrates Enhanced Chronic Inflammation, Branched Chain Amino Acids and Ketone Bodies, Biomarkers that Predict High Cardiometabolic Risk
por: Bancos, Irina, et al.
Publicado: (2022)

ODP036 Cortisol Values During the Standard-Dose Cosyntropin Stimulation Test: Personal Experience with Elecsys Cortisol II Assay
por: Hamrahian, Amir, et al.
Publicado: (2022)

OR29-2 Comprehensive Steroid and Global Metabolome Analysis by Mass Spectrometry and Machine Learning to Understand Metabolic Risk in Benign Adrenal Tumours With Mild Autonomous Cortisol Secretion
por: Prete, Alessandro
Publicado: (2022)

ODP053 Serum Free Cortisol and Free Cortisol-to-Cortisone Ratio Increase After 10 Days of Overfeeding and After 10 Days of Fasting
por: Colling, Caitlin, et al.
Publicado: (2022)

ODP041 Hearing Loss Reveals Dopamine-secreting Metastatic Paraganglioma
por: Cutrone, Lauren S, et al.
Publicado: (2022)

Quality of Life and Its Determinants in Patients With Adrenal Insufficiency: A Survey Study From Three Tertiary Centers in the United States
por: Li, Dingfeng, et al.
Publicado: (2021)

MON-169 Diagnostic Utility of Free Cortisol in Dexamethasone Suppression Test. A Prospective Study in Healthy Subjects
por: Athimulam, Shobana, et al.
Publicado: (2020)

MON-163 A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of a Selective Glucocorticoid Receptor Modulator, Relacorilant, in Patients with Autonomous Cortisol Secretion Due to Cortisol-Secreting Adrenal Adenoma(s)/Hyperplasia
por: Auchus, Richard Joseph, et al.
Publicado: (2020)

ODP144 Cushing Syndrome and Primary Hyperaldosteronism due to Synchronic Bilateral Adrenal Adenomas with Exclusive Production of Cortisol on the Right and Aldosterone on the Left
por: Rolim, Marina Rocha, et al.
Publicado: (2022)

Androgen Secreting Adenoma Co- Secreting Cortisol First Diagnosed During Pregnancy
por: Al Ghareeb, Zahra, et al.
Publicado: (2021)

OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
por: Olmos, Roberto Ignacio, et al.
Publicado: (2020)

PSUN20 The ACSPIRE Trial: 11beta-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition for Autonomous Cortisol Secretion and Adrenal Cushing's Syndrome
por: Czerwiec, Frank S, et al.
Publicado: (2022)

SUN-158 Testosterone and Cortisol Secreting Large Adreno- Cortical Adenoma
por: Madhavan, Parvathy, et al.
Publicado: (2020)

Incidence of Venous Thromboembolic Events in Patients With Endogenous Cushing Syndrome
por: Subbu, Karthik, et al.
Publicado: (2021)

SAT-376 Dynamic Modeling of the 1 mg Overnight Dexamethasone Suppression Test: Sources of Variability and Strategies to Improve Diagnostic Accuracy for Detection of Autonomous Cortisol Secretion in Adrenal Adenoma Patients
por: Kambhatla, Akshaya, et al.
Publicado: (2019)

ODP015 "Malignant" Hypertension in an Older Male
por: Naha, Sowjanya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8vlqjjlolovp7k4iuaoco8hn4l